SPONSORED:

Liberal groups call on Dem leaders to go bigger on drug price legislation

Liberal groups call on Dem leaders to go bigger on drug price legislation
© Getty

A coalition of leading liberal organizations is calling on House Democratic leaders to take bolder stances in proposing legislation to lower drug prices and go further than allowing Medicare to negotiate drug prices.

“Although Medicare negotiation is a much-needed reform, it is not the only solution needed to reach most Americans,” the letter to House Democratic leaders states. “We need reforms that lower stratospheric launch prices for new drugs and prevent price gouging on existing drugs for all payers.”

ADVERTISEMENT
The letter is signed by a range of groups that are powerful allies of congressional Democrats, including the Center for American Progress, AFL-CIO, AFSCME, Indivisible and Families USA.

The push to go bigger comes as House Democrats are in the process of putting together their drug pricing legislation.

While allowing Medicare to negotiate drug prices has long been a Democratic priority, the groups note that 56 percent of the population is covered by private insurance, so they want drug pricing reforms to apply to them too, not just to people with Medicare.

The Center for American Progress, for example, has a plan to limit drug prices that applies to both public and private insurance.

The letter is addressed to Speaker Nancy PelosiNancy PelosiDemocrats make full-court press on expanded child tax credit Maria Bartiromo defends reporting: 'Keep trashing me, I'll keep telling the truth' Democratic clamor grows for select committee on Jan. 6 attack MORE (D-Calif.), House Energy and Commerce Committee Chairman Frank Pallone Jr.Frank Joseph PalloneIntercept bureau chief: Democrats dropping support of Medicare for All could threaten bill's momentum House Democrats reintroduce road map to carbon neutrality by 2050 House Democrats criticize Texas's 'shortcomings in preparations' on winter storms MORE (D-N.J.) and House Ways and Means Committee Chairman Richard NealRichard Edmund NealBiden moves to undo Trump trade legacy with EU deal Republicans open new line of attack on IRS Ireland, loved by Biden, is obstacle to tax deal MORE (D-Mass.).

House Democrats are planning to first move a package of “low-hanging fruit” drug pricing measures that are smaller and could receive bipartisan support. The liberal groups did not object to this strategy, noting that: “We believe there may be opportunities to enact into law incremental legislation, such as legislation that makes it easier for generic drugs to come to market.”

It is in the second phase, where Democrats plan to bring forward bigger, more partisan legislation, where the groups want to go beyond just allowing Medicare to negotiate drug prices.

“We appreciate your steadfast efforts to lower prescription drug prices for the American people and stand ready to assist you in any way we can,” the letter states.